13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 2 of 9 – SEC Filing

 

CUSIP
No
.
713661502   Page
2 of 9

 

1

NAME
OF REPORTING PERSONS
Tappan Street Partners LLC

 

I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 45-2662859

 
2 CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC
USE ONLY
 
4

CITIZENSHIP
OR PLACE OF ORGANIZATION

Delaware,
United States of America

 

NUMBER
OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE
VOTING POWER

0

 
6

SHARED
VOTING POWER

2,231,577*

 
7

SOLE
DISPOSITIVE POWER

0

 
8

SHARED
DISPOSITIVE POWER

2,231,577*

 
9

AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,231,577

 
10 CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9

4.95%†

 
12

TYPE
OF REPORTING PERSON

IA

 
         

*
Tappan Street Partners LLC is the investment manager of the Tappan Street Partners Fund L.P. (the “Fund”) and the
Tappan Street Partners Ideas Fund L.P. (the “Ideas Fund” and together with the Fund, the “Funds”) in which
such shares referred to above are held. As a result, Tappan Street Partners LLC possesses the power to vote and dispose or direct
the disposition of all the shares owned by the Funds. Thus, Tappan Street Partners LLC may be deemed to beneficially own a total
of 2,231,577 shares.

 

†Based
on a total of 45,069,188 Shares outstanding of the Issuer as of July 11, 2017, as set forth in the Issuer’s most recent
Form 10-K, filed July 14, 2017.

Follow Avid Bioservices Inc. (NASDAQ:CDMO)